Profile
FEMY ISRG BDXA BDX RMD ALC
Company Name Femasys Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $11.96M $167.60B $55.91B $54.60B $40.88B $39.47B
Employees 0.07K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Kathy Lee-Sepsick Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
FEMY ISRG BDXA BDX RMD ALC
Quant Rating Score 1 3 5 3 4 3
Quant Rating Strong Sell Neutral Strong Buy Neutral Buy Neutral
Trading
FEMY ISRG BDXA BDX RMD ALC
Last Close $0.3921 $449.68 $59.24 $186.84 $270.14 $78.29
High 52 $1.77 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $0.36 $441.23 $59.24 $165.15 $204.58 $77.87
Price vs. 52 Week High -77.85 % -26.34 % 0 % -24.99 % -8.03 % -21.76 %
Price vs. 52 Week Low 8.92 % 1.92 % 0 % 13.13 % 32.05 % 0.54 %
Total Return
FEMY ISRG BDXA BDX RMD ALC
1 Month Return -48.83 % -6.83 % 0 % -4.65 % -6.32 % -9.47 %
3 Month Return -55.91 % -12.2 % 0 % 8.5 % 8.34 % -9.18 %
6 Month Return -71.99 % -5.65 % 0 % -16.14 % 22.95 % -9.81 %
9 Month Return -66.91 % -16.65 % 0 % -17.15 % 13.26 % -6.92 %
YTD Return -64.35 % -13.85 % 0 % -17.64 % 18.12 % -7.77 %
1 Year Return -64.99 % -8.2 % 0 % -20.22 % 8.52 % -20.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FEMY ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.13 % 2.18 % 0.78 % 0.42 %
Dividend Paid and Capex Coverage Ration (TTM) -26.52 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.07 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
FEMY ISRG BDXA BDX RMD ALC
Asset Growth -55.16 % 8.54 % 2.48 %
Gross Profit Growth 56.7 % 11.69 % 5.05 %
Revenue Growth 51.97 % 4.16 % 4.82 %
Revenue 3 Year -26.79 % 5.3 % 18.48 %
Revenue 5 Year -7.38 % 8.72 % 30.35 %
Revenue 10 Year -7.38 % 59.37 % 50.3 %
EBIT Growth -22.21 % 19.82 % 41.82 %
Net Income Growth -32.07 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share -32.33 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 11.83 % 28.82 % 253.24 %
Net Income 10 Yeari Growth Per Share 11.83 % -4.02 % 239.64 %
Operating Income Growth -22.59 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) -72.37 % 27.07 % 49.64 %
Operating 3 Year CFG -29.97 % -18.4 % 53.05 %
Operating 5 Year CFG 6.69 % 6.25 % 122.93 %
Operating 10 Year CFG 6.69 % 45.28 % 55.79 %
EPS Growth 9.68 % 18.31 % 4.04 %
EPS Diluted Growth 9.68 % 18.62 % 4.59 %
Book Value Per Share -91.33 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share -95.36 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share 102.68 % 14.4 % 10.26 %
Share Holder 10 Year Equity Growth Per Share 102.68 % 241.78 % -9.87 %
Dividend Per Share Growth - -2.44 % 11.75 %
Dividend 3 Year Growth Per Share - 4.79 % 138.09 %
Dividend 5 Year Growth Per Share - 4.14 % -
Dividend 10 Year Growth Per Share - 74.3 % -
Debt Growth 11.06 % 31.74 % 0.02 %
Free Cash Flow Growth -76.86 % 45.25 % 162.01 %
Updated On 31 Dec 2024 30 Sep 2024 31 Dec 2024
Profitability
FEMY ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 53.71 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM -864.98 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM -713.69 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 224.43 % 14.26 % 5.78 % 5.78 % 23.58 % 4.98 %
Net Income Per EBT TTM 100.03 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 109.68 % 113.2 % 70.86 % 70.86 % 99.42 % 86.96 %
EBIT Per Revenue TTM -1015 % 28.8 % 12.63 % 12.63 % 32.79 % 14.38 %
Cash Flow To Debt Ratio TTM -250.46 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 7.41 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 0.27 11.43 - 1.85 7.52 5.03
Inventory Turnover TTM 0.17 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 60.01 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 77.67 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -0.68 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.71 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 11.14 % 1485.77 % 262.85 % 262.85 % 834.65 % 284.33 %
Operating Cash Flow Sales Ratio TTM -1042.24 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.77 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -250.46 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -0.59 84.04 21.5 21.41 24.64 24.7
Price To Operating Cash Flows Ratio TTM -0.54 59.31 16.93 16.86 23.35 19.17
Price Cash Flow Ratio TTM -0.54 59.31 16.93 16.86 23.35 19.17
Income Statement (TTM)
FEMY ISRG BDXA BDX RMD ALC
Revenue $0B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 66.55% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $-0.02B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted -0.84 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
FEMY ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0.01B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $0B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $0.01B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.01B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
FEMY ISRG BDXA BDX RMD ALC
Net Income $-0.02B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $-0.02B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.29
ANGO AngioDynamics, Inc. 10.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 135.23
ATRC AtriCure, Inc. 35.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 29.66
BAX Baxter International Inc. 23.99
BDX Becton, Dickinson and Company 186.84
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.19
BLFS BioLife Solutions, Inc. 25.51
COO The Cooper Companies, Inc. 66.68
DXR Daxor Corporation 11.66
EKSO Ekso Bionics Holdings, Inc. 3.83
GCTK GlucoTrack, Inc. 10.59
ETFs With Exposure to FEMY
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 324.31
VXF Vanguard Extended Market Index Fund 0.00023 208.84
IWC iShares Micro-Cap ETF 0.00207 145.77
DFAS Dimensional U.S. Small Cap ETF 0.00006446 68.55
VTSAX Vanguard Total Stock Market Index Fund 0 157.86
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00023 158.47
VITSX Vanguard Total Stock Market Index Fund 0 157.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00023 158.48
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 488
VEMPX Vanguard Extended Market Index InstlPlus 0.00023 391.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 296.18
Unlock